PrEP for Prevention: Optimizing Sexual Health and Decreasing HIV Risk
Infectious diseases | October 5, 2020
Launch Date:
October 5, 2020
Expiration Date:
October 5, 2021
primary audience:
Nurse practitioners, Physician assistants, Primary care physicians
Relevant Terms:
Hiv prevention, Preexposure prophylaxis, Prep
course faculty
Isolde Butler, MD (Co-Chair)
Dr. Isolde Butler attended Yale University in New Haven, Connecticut, where she earned her undergraduate degree in Molecular, Cellular, and Developmental Biology in 2001, before earning her Master of Public Health in Tropical Medicine at the Tulane School of Public Health in New Orleans, Louisiana, in 2005. She received her medical degree in the same year from the Tulane School of Medicine and completed her residency at the Tulane University Internal Medicine Residency Program. She is board certified in internal medicine and infectious disease.
Jason Halperin, MD, MPH
Dr. Jason Halperin is an assistant professor of medicine at Tulane University’s School of Medicine and HIV/ID Innovation Medical Leader at CrescentCare. He received his master of public health from Columbia University in New York, New York in 2006, and went on to earn his medical degree from the University of Vermont College of Medicine in Burlington, Vermont, in 2010. He fulfilled a residency at the Tulane University Department of Internal Medicine in New Orleans, Louisiana, and served on the Tulane University Medical Center Ethics Committee. Following residency, Dr. Halperin completed an infectious diseases fellowship at New York University in New York, New York, then returned to New Orleans in 2015 to join CrescentCare. His areas of interest are HIV, hepatitis C virus, and HIV prevention services, such as preexposure prophylaxis (PrEP). Dr. Halperin strongly believes in the importance of clinical research and is implementing clinical trials at CrescentCare.
Neil Skolnik, MD (Moderator)
learning objectives
1. Demonstrate understanding of the epidemiology, burden, and stigma surrounding HIV risk and transmission
2. Initiate a patient-clinician dialogue to discuss and assess sexual health and behaviors and determine HIV risk
3. Utilize US Public Health Service (USPHS)/Centers for Disease Control and Prevention (CDC) Clinical Practice Guidelines: PrEP for the Prevention of HIV in the United States to appropriately screen and determine eligibility for PrEP
4. Initiate and provide ongoing monitoring for patients on PrEP for HIV prevention
course information
Educational Objectives
After completing this activity, the participant should be better able to:
• Demonstrate understanding of the epidemiology, burden, and stigma surrounding HIV risk and transmission
• Initiate a patient-clinician dialogue to discuss and assess sexual health and behaviors and determine HIV risk
• Utilize US Public Health Service (USPHS)/US Centers for Disease Control and Prevention (CDC) clinical practice guidelines: Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection in the United States to appropriately screen and determine clinical eligibility for PrEP
• Initiate and provide ongoing monitoring for patients on PrEP for HIV prevention
This activity is presented by National Association for Continuing Education and Integritas Communications.
COURSE SUMMARY
Initiating an open and honest conversation with patients about their sexual health and determining clinical eligibility for preexposure prophylaxis (PrEP) is often challenging to many primary care providers (PCPs) who may feel uncomfortable and unprepared. This one-hour enduring webcast is designed to increase awareness among PCPs of their role in human immunodeficiency virus (HIV) prevention, provide practical tools to improve their comfort and skills in opening dialogues about sexual health, and prepare them to provide full PrEP services.
PLANNING COMMITTEE
Michelle Frisch, MPH, CHCP
Vice President, Operations
National Association for Continuing Education
Plantation, FL
Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL
Deborah Paschal, CRNP
Clinical Nurse Practitioner
Philadelphia, PA
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL
Becky Carney, MSPT
Senior VP, Educational Strategy
Integritas Communications Group
Hoboken, NJ
Jim Kappler, PhD
Integritas Communications Group
Hoboken, NJ
Christa Master
Vice President, Account Services
Integritas Communications Group
Hoboken, NJ
Stacey JP Ullman, MHS
Vice President, Scientific Services
Integritas Communications Group
Hoboken, NJ
Jeanette Ruby, MD
Vice President, Scientific Services
Integritas Communications Group
Hoboken, NJ
Accreditation Information
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and Integritas Communications. NACE is accredited by the ACCME to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education, which includes 1.0 pharmacology hour.
DISCLOSURE POLICY
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a NACE-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. All faculty, moderator and planner conflicts of interest have been resolved through peer review of the content by the Course Director and/or agreement to NACE conflict of interest resolution policies.
The ACCME defines a commercial interest as an entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME does not consider providing clinical service directly to patients to be commercial interests – unless the provider of the clinical service is owned, or controlled by, an ACCME-defined commercial interest.
Resolution of Personal Conflicts of Interests
NACE requires disclosure of relevant financial relationships with the commercial interest from course directors, faculty, members of the activity planning committee, and others in a position to control the content of the educational activity. Any individual who refuses to disclose his or her relationships will be disqualified from any involvement in the planning, development, teaching/presenting, managing, or evaluation of the educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:
Jason Halperin, MD, MPH: No financial relationships to disclose
Isolde Butler, MD, MPH: No financial relationships to disclose
Neil Skolnik, MD: Advisory Board Member: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Intarcia Therapeutics, Inc., Janssen, Merck & Co., Inc., Mylan, Sanofi Pasteur, Teva; Research: AstraZeneca, Boehringer Ingelheim, Sanofi; Speaker: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline
The planning committee reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:
Michelle Frisch, MPH, CHCP: No financial relationships to disclose
Sheila Lucas, CWEP: No financial relationships to disclose
Deborah Paschal, CRNP: No financial relationships to disclose
Gregg Sherman, MD: No financial relationships to disclose
Becky Carney, MSPT: No financial relationships to disclose
Christa Master: No financial relationships to disclose
Stacey JP Ullman, MHS: No financial relationships to disclose
Jeanette Ruby, MD: No financial relationships to disclose
Jim Kappler, PhD: No financial relationships to disclose
STATEMENT OF COMMERCIAL SUPPORT
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the posttest and program evaluation. Your posttest will automatically be graded. If you successfully complete the posttest (score of 75% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 75%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. |
Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above
|
Related Courses
Screen. Treat. Overcome. Prevent. S.T.O.P. HIV - Patient Huddle
infectious diseases
|
Oct 1, 2019
This activity is good for 0.50 AMA PRA Category 1 Credit(s)™, or 0.50 Continui...
Launches:
Oct 1, 2019
Expires:
Nov 22, 2021
High-Risk Patients with COVID-19: Outpatient Management to Prevent Pro...
COVID-19
|
Aug 24, 2021
PROGRAM DESCRIPTION Patients with COVID-19 have varied risk for increasing severity of disease, with...
.25AMA
0.25AANP
Launches:
Aug 24, 2021
Expires:
Aug 24, 2022
Practical Solutions Across the Spectrum of Care - HIV in Women
infectious diseases
|
Oct 30, 2020
This activity is jointly provided by Postgraduate Institute for Medicine and Integritas...
0.50AMA
Launches:
Oct 30, 2020
Expires:
Oct 30, 2021
